
GLP-1s bring the opportunity for gyms to shed the weight loss stereotype (Image: unsplash.com/@siora18)
For decades, weight loss has dominated the way fitness has been marketed. But, at last, the reasons industry professionals promote services to people looking to exercise appear to be becoming broader.
With GLP-1 medications taking the attention of “weight loss” seekers, it creates a significant opportunity for gyms and marketing departments in particular to share more services and facilities at scale.
Read the latest issue of WellNation
Sport England’s Activity Check-in regularly tracks attitudes, motivations and barriers around physical activity, providing the sector with a more frequent view of how consumer behaviour is changing. Alongside participation data, it explores why people want to be active and the pressures influencing those decisions.
Increasingly, the conversation around exercise encompasses mental wellbeing, strength, mobility, confidence, and social connection. These are benefits that extend well beyond appearance. Sport England’s research also consistently associates greater physical activity with higher mental wellbeing.
Doing better than “are you looking to lose weight?”
For operators and trainers, that changing conversation matters because members themselves can help shape the next generation of fitness services. Listening to why people train and what they want to remain capable of doing will influence programming, coaching, and especially marketing.
The rapid growth of GLP-1 weight-management medications is likely to accelerate that shift further.
Updated UK Chief Medical Officers’ guidance, published in July 2026, specifically highlights the importance of maintaining strength while using GLP-1 drugs because weight reduction can include loss of muscle as well as fat. NHS England guidance these meds similarly recommends resistance and strength-focused activity as a cornerstone of health rather than focusing on weight loss alone.
Research highlighted by ukactive and Les Mills estimates that 20–50% of weight lost through these medications can be lean body mass, reinforcing the potential role of structured strength training.
Weight loss is no longer the best thing on the menu. So, what’s next?
We knew the need for strength training, even before it was recommended to accompany the use of GLP-1s and similar prescriptions. However, what we haven’t been talking about is the opportunity to embrace this shift in awareness, advice, and association.
This cultural nudge gives the fitness industry a powerful proposition. If medication increasingly helps people lose weight, gyms can help them become stronger, fitter, more mobile and healthier for longer.
The industry has entered a period where selling weight loss is much less of a draw. Now is the time that more fitness professionals can start helping people build what comes next.



